<?xml-stylesheet type="text/xsl" href="https://dochub.sk.ru/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>One of the leading US biotechnology venture funds enters into investor accreditation agreement with the Skolkovo Foundation</title><link>/news/b/pressreleases/archive/2012/08/06/one-of-the-leading-us-biotechnology-venture-funds-enters-into-investor-accreditation-agreement-with-the-skolkovo-foundation.aspx</link><description>The Skolkovo Foundation and Oxford Bioscience Partners signed the memorandum of understanding. The venture fund will look to invest at least $10 million in Skolkovo. 
 The Skolkovo Foundation and Oxford Bioscience Partners announced the signing of the</description><dc:language /><generator>7.x Production</generator></channel></rss>